MJA InSight ARTICLE

Triple drug therapy for newly diagnosed myeloma – when is more, better?

Authored by: Professor H. Miles Prince AM, Director of Cancer Immunology & Molecular Oncology, Epworth Healthcare

Media contacts
Julia Slater 
0422 074 354/  (02) 9968 3741
VIVA! Communications
Buildings 5 & 6, 1110 Middle Head Rd
Mosman, NSW, 2088